Hardman & Co: Sustained and sustainable NAV growth
Hardman & Co Research: 2020 results: sustained and sustainable NAV growth
OCI's 2020 results were strong. Through this challenging year, i) the total NAV return reached 18%, ii) 10 companies representing 44% of NAV met or exceeded pre-COVID-19 expectations, and only three (13% of NAV) were significantly impacted, iii) both investments and realisations continued strongly (£152m and £341m, respectively), iv) year-end cash was £223m, giving huge firepower to take current opportunities, and v) potentially disruptive large share overhangs have been sold out. The digital focus, concentration on structural growth markets and Oakley's unique repeatable origination from its network of entrepreneurs bode well for the future.
Please click on the link below for the full report:
If you are interested in meeting the company, you can register your interest by clicking on the above link
To contact us:
1 Frederick's Place
Follow us on Twitter @HardmanandCo
Hardman & Co Research can still be accessed for free after MiFID II. Pleaseclick hereto read the statement.
About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.
Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.
Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
Kallelse till extra bolagsstämma i NanoCap Group AB
Aktieägare som vill delta i stämman ska dels vara upptagen i utskrift av aktieboken avseende förhållandena den 24 oktober 2023, dels anmäla sig till bolaget senast den 27 oktober 2023 skriftligen till Box 5141, 102 43 Stockholm eller via e-post till [email protected]. Anm...
Bioextrax: Capacity to accommodate rising interest
American start-up company exercises option for the next periodWarrants subscription adds SEK 10.6 million before issue costsOur model implies a fair valuation of SEK 10.5 per shareBioextrax shows continued progress in its Q2 report for 2023. The company signed a license agreement with the US start-u...